Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Hoboken, NJ

3 abstracts

Abstract
Adherence and persistence of encorafenib in combination with cetuximab among patients with BRAF metastatic CRC in the United States (US) based on two claims databases.
Org: Genesis Research Group, Hoboken, NJ,
Abstract
Patient characteristics and treatment patterns in BRAF-mutated unresectable or metastatic melanoma in the United States: A snapshot from real-world data.
Org: Pfizer Inc., London, United Kingdom, Kirkland, QC, Canada, Pfizer, Inc., Cambridge, MA, Pfizer,
Abstract
Patient characteristics, treatment patterns, and clinical outcomes among patients with de novo advanced or metastatic (stage IIIB–IV) non-small cell lung cancer in a real-world setting.
Org: EMD Serono Research & Development Institute, Rockland, MA, Genesis Research, Hoboken, NJ, Memorial Sloan Kettering Cancer Center,